Sponsor pipeline

Akero Therapeutics, Inc clinical trial pipeline

Get alerts when Akero Therapeutics, Inc's trials change

3 active trials 2 recruiting 3 Phase 3 1 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-20
Trial sites expanded: 323 → 329 locations
NCT06528314 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH · Phase 3

Active trials by phase

Phase 3
3

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT06528314 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH NASH - Nonalcoholic Steatohepatitis Recruiting 2026-08-19
NCT06215716 A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic… NASH With Fibrosis Recruiting 2026-08-07
NCT06161571 A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic… NASH/MASH Active, Not Recruiting 2026-04-30

Disease areas by active trials

NASH / MASH (3)

Get alerts when Akero Therapeutics, Inc's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free